Syneos Health Signs Multiyear Partnership with Microsoft to Use AI Technology
Syneos Health has signed a multiyear deal with Microsoft to use its artificial intelligence technologies. Financial details and the length of the contract weren’t disclosed.
North Carolina-based Syneos secured the agreement to use its Microsoft Azure services, which has been using an analytics platform and machine learning to support its efforts in clinical trials and commercial programs.
“Microsoft is the ideal technology partner for Syneos Health,” said Michelle Keefe, CEO, Syneos Health. “Their clear industry leadership in AI and their pragmatic approach to improving healthcare outcomes for patients, science and industry is completely aligned with our value proposition.”
By creating a platform that makes use of the Azure cloud computing platform, as well as leveraging developments by OpenAI, Syneos’ goal is to analyze data to fast-track timelines, optimize resource allocation and unlock clinical trial efficiencies. The company said this will potentially allow new therapies to come to market faster.
Microsoft has been inking several deals in the API space with major manufacturers, including Novo Nordisk, who will be paying for its AI to speed up drug development.